Hem › Melanom › Connecticut › New Haven
Kliniska studier för Melanom i New Haven, CT
10 studier för Melanom söker deltagare vid platser i och runt New Haven (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
RekryterarFas 2
- Yale Cancer Center, New Haven
Phase 1 Study of PF-08046033 in Advanced Solid Tumors
RekryterarFas 1
- Smilow Cancer Hospital - Yale New Haven Health, New Haven
- Yale - New Haven Hospital - Yale Cancer Center, New Haven
- Smilow Cancer Hospital Phase 1 Unit, New Haven
- och 1 fler
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
RekryterarFas 3
- Yale Cancer Center, New Haven
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
RekryterarFas 1/2
- Yale University, New Haven
Project: Every Child for Younger Patients With Cancer
RekryterarObservationsstudie
- Yale University, New Haven
A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
RekryterarFas 1/2
- Yale School of Medicine, North Haven · 7 mi bort
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
RekryterarFas 1/2
- Yale University, New Haven
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Rekryterar
- Yale University, New Haven
- Smilow Hospital Care Center, Guilford, Guilford · 13 mi bort
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
RekryterarFas 1/2
- Yale Cancer Center, New Haven
Phase II Trial of Neoadjuvant and Adjuvant IO102-IO103 and Pembrolizumab KEYTRUDA® in Patients With Resectable Tumors
RekryterarFas 2
- Yale, New Haven
Melanom-studier i andra städer
- Houston, TX59 studier
- New York City, NY38 studier
- Los Angeles, CA34 studier
- Nashville, TN33 studier
- Pittsburgh, PA31 studier
- Boston, MA26 studier
- Philadelphia, PA23 studier
- San Francisco, CA22 studier
- Atlanta, GA21 studier
- Durham, NC21 studier
- St. Louis, MO21 studier
- Columbus, OH21 studier
Andra studier i New Haven
- Icke-småcellig lungcancer41 studier
- Bröstcancer37 studier
- Cancer (alla typer)33 studier
- Metastaserande cancer23 studier
- Lungcancer22 studier
- Plattenepitelcancer i huvud och hals22 studier
- Äggstockscancer21 studier
- Kolorektal cancer20 studier
- Prostatacancer20 studier
- Opioidöverdos18 studier
- Alkoholmissbruk (AUD)17 studier
- Akut myeloid leukemi17 studier
Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.